Skip to main content
Rebecca G. Kim
( out of 43 reviews )

Rebecca G. Kim, MD, MAS

Languages spoken: English

Clinical Locations

Primary Location

Redwood Health Center

1525 West 2100 South
Salt Lake City , UT 84119

Boise Area Specialty Clinic

3875 East Overland Road
Meridian , ID 83642

Clinical Profile

Rebecca G Kim, MD, MAS is a transplant and general hepatologist at the University of Utah School of Medicine. She specializes in the care of patients with chronic liver disease, cirrhosis, patients being evaluated for a liver transplant and those who have received a liver transplant. Dr. Kim grew up in Salt Lake, and then traveled around the country for her training. She received her medical degree from the University of Cincinnati College of Medicine and completed her internal medicine residency at the University of California San Diego. She stayed in San Diego for an additional year to work as a Chief Medicine Resident, and then completed her gastroenterology and transplant hepatology fellowships at the University of California San Francisco.

Dr. Kim feels passionately about caring for patients with any stage of liver disease and truly enjoys the long-term relationship she gets to build with her patients. She sees patients with viral, genetic, and autoimmune causes of liver disease, and specifically focuses on alcohol-associated liver disease and metabolic dysfunction-associated steatotic liver disease. She is also particularly interested in caring for and conducting research focused on patients with liver disease who also have social needs or unique barriers to healthcare access.

Academic Profile

Rebecca G Kim, MD, MAS is a health services researcher and hepatologist at the University of Utah School of Medicine. She obtained her medical degree at the University of Cincinnati and completed her residency, chief resident year, and gastroenterology and transplant hepatology fellowships in California at the University of California San Diego and University of California San Francisco, respectively. In San Francisco, she completed a research fellowship under the mentorship of Dr. Mandana Khalili and obtained a Master in Advanced Studies in clinical research with a specialization in Implementation Science. Her research focuses on health disparities observed among patients with chronic liver disease and outcomes related to liver disease, liver cancer, and liver transplant.

She is currently working with co-mentors Jennifer Price, MD, PhD at the University of California San Francisco, and Molly Conroy, MD, MPH and John Inadomi, MD at the University of Utah investigating the impact of social determinants of health (SDoH) on the risk and progression of chronic liver disease. Dr. Kim hopes to better understand how SDoH affect liver disease and how hepatology providers and the healthcare system may be able to help patients address SDoH to improve their liver health.

Board Certification

American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Gastroenterology)
American Board of Internal Medicine (Sub: Transplant Hepatology)

Patient Rating

Feedback is overwhelmingly positive, with 29 of 31 reviews rated 5 stars. Patients repeatedly note that the physician listens carefully, explains treatment and care plans clearly, and is knowledgeable, thorough, caring, and professional. A small number of four-star reviews still described visits as informative or very good, so overall sentiment remains strongly positive.

Generated via Patient Reviews

4.8 /5
( out of 43 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


May 14, 2026
REDWOOD HEALTH CENTER

Dr. Kim is very caring and concerned about my health. She is very helpful in making decisions that will help me

Feb 06, 2026
UNIVERSITY HOSPITAL

Very knowledgeable and very professional!

Jan 29, 2026
REDWOOD HEALTH CENTER

Dr Rebecca Kim is an amazing doctor & I'm thankful to be under her care. She always listens & explains everything about my care plan at each visit and I feel she's there for me inbetween visits ready to answer any questions I may have with regards any blood labs. I'm grateful for Dr Rebecca Kim.

Jun 26, 2025
REDWOOD HEALTH CENTER

Dr Kim does an excellent job. She listens. She cares. She is very smart in her practice.

Jun 26, 2025
REDWOOD HEALTH CENTER

Very thorough and caring. Knowledgeable and understanding

May 10, 2025
UNIVERSITY HOSPITAL

We love Dr Kim!

Apr 24, 2025
REDWOOD HEALTH CENTER

Dr. Kim is a caring and concerned doctor who wants me to get the best care I possibly can.

Apr 01, 2025
REDWOOD HEALTH CENTER

Dr. Kim is caring and professional

Feb 27, 2025
REDWOOD HEALTH CENTER

Dr. Kim portrays the skills and fortitude of a great liver doctor. She is very knowledgeable of the issues that effect me as a patient.

Jan 04, 2025
UNIVERSITY HOSPITAL

Dr. Kim is very knowledgeable, patient, and kind. She answered all my questions, addressed my major concerns as I make an important medical decision. Grateful for her honesty and straight forwardness.

Nov 29, 2024
REDWOOD HEALTH CENTER

Dr Rebecca Kim is the most thorough and thoughtful doctor I have ever had. She listens and learns from her patients. Tumbs up and Thank You to Dr Kim

Oct 31, 2024
UH HOSPITALS AND CLINICS

Dr Kim is very helpful and courteous . Listens and answers all my comments and questions.

Jul 10, 2024
REDWOOD HEALTH CENTER

Best visit I have had in 23 years at the U of U. Dr. KIM and her assitant are personable and professional. Thanks for making me feel like you do really care about me.

Jul 05, 2024
REDWOOD HEALTH CENTER

She a very good doctor. One that I would go to because she very professional and listens to what I have to say. I'm very pleased with her.

Jun 02, 2024
UH HOSPITALS AND CLINICS

Dr Kim takes great care and answers questions completely. She relays the treatment options in an understandable manner. I feel like I received superior care.

Apr 11, 2024
UH HOSPITALS AND CLINICS

Rebecca is a excellent doctor.

Mar 09, 2024
REDWOOD HEALTH CENTER

Dr. Rebecca Kim is a talented physician and surgeon and I would trust her again with my life

Mar 05, 2024
UH HOSPITALS AND CLINICS

Thank you Rebecca for listening to my concerns

Feb 23, 2024
REDWOOD HEALTH CENTER

Rebecca G Kim is excellent. She listened to my symptom and explain the treatment that she is giving to me to treat the Hepatitis B. She made sure I understood and her treatments. Thanks so much Dr. Rebecca.

Feb 22, 2024
REDWOOD HEALTH CENTER

Very pleased with her care and knowledge

Feb 21, 2024
REDWOOD HEALTH CENTER

Extremely helpful and very thorough!

Feb 10, 2024
UH HOSPITALS AND CLINICS

She and all the doctors and nurses all involved coordinators are fan tastic

Feb 08, 2024
REDWOOD HEALTH CENTER

Dr. Rebecca Kim explained things in a way that made sense. She was personable and made me feel good. I would go back.

Nov 01, 2023
UH HOSPITALS AND CLINICS

The Physician was personable, relatable, knowledgeable and very easy to communicate with. She was thorough both in exam and in communication of plan of care. She was professional and caring.

Aug 23, 2023
REDWOOD HEALTH CENTER

Dr. Kim is very caring and knowledgeable. She took the time to understand my health problems and to research any causes. I am now recovering and owe a great deal to Dr. Kim and her team.

Aug 18, 2023
REDWOOD HEALTH CENTER

Dr Kim looked to young to be a Dr. She did a great. Very knowledgeable. Very thorough. Kind, she explained my situation and worked out a plan of action. Thank You

Aug 17, 2023
REDWOOD HEALTH CENTER

Very informative

Feb 12, 2023
REDWOOD HEALTH CENTER

Very good

Feb 11, 2023
REDWOOD HEALTH CENTER

I love Dr. Kim. So thorough and knowledgeable but also attentive and interested in what I had to say.

Jan 30, 2023
REDWOOD HEALTH CENTER

great doctor; attentive and responsive

Jan 15, 2023
REDWOOD HEALTH CENTER

Very informative she is!


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Clinical Profile

Rebecca G Kim, MD, MAS is a transplant and general hepatologist at the University of Utah School of Medicine. She specializes in the care of patients with chronic liver disease, cirrhosis, patients being evaluated for a liver transplant and those who have received a liver transplant. Dr. Kim grew up in Salt Lake, and then traveled around the country for her training. She received her medical degree from the University of Cincinnati College of Medicine and completed her internal medicine residency at the University of California San Diego. She stayed in San Diego for an additional year to work as a Chief Medicine Resident, and then completed her gastroenterology and transplant hepatology fellowships at the University of California San Francisco.

Dr. Kim feels passionately about caring for patients with any stage of liver disease and truly enjoys the long-term relationship she gets to build with her patients. She sees patients with viral, genetic, and autoimmune causes of liver disease, and specifically focuses on alcohol-associated liver disease and metabolic dysfunction-associated steatotic liver disease. She is also particularly interested in caring for and conducting research focused on patients with liver disease who also have social needs or unique barriers to healthcare access.

Academic Profile

Rebecca G Kim, MD, MAS is a health services researcher and hepatologist at the University of Utah School of Medicine. She obtained her medical degree at the University of Cincinnati and completed her residency, chief resident year, and gastroenterology and transplant hepatology fellowships in California at the University of California San Diego and University of California San Francisco, respectively. In San Francisco, she completed a research fellowship under the mentorship of Dr. Mandana Khalili and obtained a Master in Advanced Studies in clinical research with a specialization in Implementation Science. Her research focuses on health disparities observed among patients with chronic liver disease and outcomes related to liver disease, liver cancer, and liver transplant.

She is currently working with co-mentors Jennifer Price, MD, PhD at the University of California San Francisco, and Molly Conroy, MD, MPH and John Inadomi, MD at the University of Utah investigating the impact of social determinants of health (SDoH) on the risk and progression of chronic liver disease. Dr. Kim hopes to better understand how SDoH affect liver disease and how hepatology providers and the healthcare system may be able to help patients address SDoH to improve their liver health.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor
Academic Divisions Gastroenterology
Board Certification
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Gastroenterology)
American Board of Internal Medicine (Sub: Transplant Hepatology)

Education history

Undergraduate Biochemistry - Colgate University B.A.
Graduate Training Physiology - University of Cincinnati College of Medicine M.S.
Professional Medical Medicine - University of Cincinnati College of Medicine M.D.
Residency Internal Medicine - University of California, San Diego School of Medicine Resident
Residency Internal Medicine - University of California, San Diego School of Medicine Chief Resident
Fellowship Gastroenterology and Hepatology - University of California, San Francisco Fellow
Graduate Training Clinical Research with Specialization in Implementation Science - University of California, San Francisco M.A.S.
Fellowship Hepatology - University of California, San Francisco Research Fellow
Fellowship Advanced/Transplant Hepatology - University of California, San Francisco Fellow

Selected Publications

Journal Article

  1. Patel S, Khalili M, Singal AG, Pinheiro PS, Jones PD, Kim RG, Kode V, Thiemann A, Zhang W, Cheung R, Wong R (2025). Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors. Cancer epidemiology, biomarkers & prevention, 34(2), 355-365.
  2. Kim RG, Ballantyne A, Codden RR, Millar MM, Wallace A, Inadomi JM, Conroy MB, Price J (2025). Feasible and acceptable social drivers of health screening among patients with chronic liver disease. Hepatology communications, 9(7),
  3. Kim RG, Patel S, Satre DD, Shumway M, Chen JY, Magee C, Wong RJ, Monto A, Cheung R, Khalili (2024). Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease. Digestive diseases and sciences,
  4. Kim RG, Ballantyne A, Conroy MB, Price JC, Inadomi J (2024). Screening for social determinants of health among populations at risk for MASLD: a scoping review. Frontiers in public health, 12, 1332870.
  5. Patel S, Kim RG, Shui AM, Magee C, Lu M, Chen J, Tana M, Huang CY, Khalili (2024). Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use. Gastro hep advances, 3(1), 84-94.
  6. Medina SP, Kim RG, Magee C, Stapper N, Khalili (2023). Cross-sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease. Obesity science & practice, 9(6), 581-589.
  7. Morris MD, McDonell C, Kim RG, Laguardia Y, Kanner R, Price J (2023). A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs. Clinical liver disease, 22(3), 81-84.
  8. Kim RG, Kramer-Feldman J, Bacchetti P, Grimes B, Burchard E, Eng C, Hu D, Hellerstein M, Khalili M (2022). Disentangling the impact of alcohol use and hepatitis C on insulin action in Latino individuals. Alcohol Clin Exp Res, 46(1), 87-99.
  9. Kim RG, Chu JN, Vittinghoff E, Deng J, Reaso JN, Grenert JP, Khalili (2022). Racial/ethnic differences in fibrosis prevalence and progression in biopsy-proven steatosis: A focus on the Asian American population. Hepatology communications, 6(11), 3024-3035.
  10. Kim RG, Khalili (2022). Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body mass. Obesity science & practice, 9(2), 190-199.
  11. Kim RG, Deng J, Reaso JN, Grenert JP, Khalili (2022). Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy. Diabetes care, 45(10), 2449-2451.
  12. Kim RG, Medina SP, Magee C, Khalili M (2021). Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations.(Epub ahead of print). Hepatol Commun.
  13. Akeno N, Reece AL, Callahan M, Miller AL, Kim RG, He D, Lane A, Moulton JS, Wikenheiser-Brokamp KA (2017). TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response. Mol Cancer Ther, 16(12), 2913-2926.
  14. Kim RG, Nguyen P, Bettencourt R, Dulai PS, Haufe W, Hooker J, Minocha J, Valasek MA, Aryafar H, Brenner DA, Sirlin CB, Loomba R (2016). Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study. Aliment Pharmacol Ther, 44(3), 287-99.
  15. Schurman SH, Dunn CA, Greaves R, Yu B, Ferrucci L, Croteau DL, Seidman MM, Bohr VA (2012). Age-related disease association of endogenous γ-H2AX foci in mononuclear cells derived from leukapheresis. PLoS One, 7(9), e45728.
  16. Nolen EG, Donahue LA, Greaves R, Daly TA, Calabrese DR (2008). Syntheses of alpha- and beta-C-glucopyranosyl serines from a common intermediate. Org Lett, 10(21), 4911-4.
  17. Palaniappan KK, Gao ZG, Ivanov AA, Greaves R, Adachi H, Besada P, Kim HO, Kim AY, Choe SA, Jeong LS, Jacobson KA (2007). Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides. Biochemistry, 46(25), 7437-48.

Review

  1. Kim RG, McDonell C, Burbank S, Morris MD, Price J (2023). Telemedicine Acceptability and Experience in a Marginalized Population at Risk for Hepatitis C Virus. Gastro hep advances, 3(1), 64-66.
  2. Kim RG, Loomba R, Prokop LJ, Singh S (2017). Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. [Review]. Clin Gastroenterol Hepatol, 15, (10), 1521-1530.e8.

Case Report

  1. Kraft C, Kim RG, Kathpalia P (2021). Recurrent Lower Gastrointestinal Bleeding due to a Cholecystocolonic Fistula. Am J Gastroenterol, 116(9), 1825.

Editorial

  1. Bhardwaj NJ, Kim R (2025). Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia. Alimentary pharmacology & therapeutics, 61(4), 727-728.
  2. Kim RG, Loomba (2016). Editorial: non-invasive assessment of hepatic fibrosis in alpha-1 antitrypsin deficiency using magnetic resonance elastography - authors' reply. Alimentary pharmacology & therapeutics, 44(6), 645-6.